Latest Updates

Hospital business of Apotex will not form part of the merged entity and will be retained by Apotex

Products are being developed for cognitive disorders with high unmet medical need and with huge market potential globally

Etanercept (YLB113) is indicated for moderate to severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis

It is used for the treatment of schizophrenia and bipolar disease

CDSCO announces one year extension of WHO-GMP certifications

It will be the largest overseas acquisition by a Japanese company

After remaining in the negative territory for the first five months of the financial year 2017-18, pharma exports have picked up…

The findings could help combat associated diseases and advance crop protection

The product is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses

The facility near Hyderabad underwent inspection from February 5-18, 2018

According to the US FDA, the nationwide, voluntary and ongoing recall is a Class II recall

The Research was funded by the grant from the Department of Biotechnology

The conference was supported by ICMR, UNICEF and DST

These genetic clocks could help build more complex genetic networks for drug delivery, and even introduce a personalised medicine…

The finding is surprising because aspirin is reported to reduce risk of gastric, colon, prostate and breast cancer

The move would help India to export these pharma products to the neighbouring country.

Cell therapy Kymriah is also approved for adults with high grade B-cell lymphoma and diffuse large B-cell lymphoma arising from…

EDITDA margins improves from 7.6 per cent to 10.7 per cent

The company has received final approval from US FDA

In year ended FY 2018, the company's income from operations was at Rs 2,131 crore against Rs 2,002 crore